-
elucidation of membrane protein complexes and integrates fundamental cell biology and structural biology by cryo- electron microscopy. The lab has a strong track record in investigating scramblases and their
-
data. We have developed in vivo single-cell CRISPR technologies to screen for dozens of molecular factors in vivo during developmental and disease. These technologies are a game-changer in the speed
-
mimicked with in vivo models of metastasis, which provides unique opportunities to mechanistically dissect what drives the different cell states. You will link clinically relevant phenotypes to putative
-
prodromal cohorts and link them to clinical readouts and α-synuclein reactivity. Use cutting-edge single-cell and immune-profiling approaches, linked to clinical phenotyping, to discover early biomarkers and
-
early onset (typically between ages 50–60) and its profound effects on personality, insight, and language. Although both diseases are defined by the aggregation of specific pathological proteins in a